[Advances in Liquid Biopsy and its Clinical Application in the Diagnosis and Treatment of Non-small Cell Lung Cancer]
- PMID: 27335304
- PMCID: PMC6015208
- DOI: 10.3779/j.issn.1009-3419.2016.06.19
[Advances in Liquid Biopsy and its Clinical Application in the Diagnosis and Treatment of Non-small Cell Lung Cancer]
Abstract
With the advances of technology, great progresses have been made in liquid biopsy in recent years. Liquid biopsy is currently playing a more and more important role in early diagnosis and treatment of cancer. Compared with traditional tissue biopsy, liquid biopsy is more popular in clinical practice due to its non-invasiveness, convenience and high repeatability. It has huge potential in the future. This review introduces circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as the most important objects in liquid biopsy, mainly focusing on their history, biological characteristics, detection technologies, limitations and applications in non-small cell lung cancer.
随着近几年科学技术的进步,液体活检技术也有了长足的发展,并在肿瘤的早期诊断及后期治疗中扮演着越来越重要的角色。相比于传统的组织活检,液体活检以其独有的无创性、便捷性、高重复性等特点在临床上得到更多的青睐,在未来有着巨大的发展潜力。本文重点探讨了循环肿瘤细胞(circulating tumor cells, CTCs)和循环肿瘤DNA(circulating tumor DNA, ctDNA),作为液体活检最重要的两个检测对象,其历史、生物学特性,检测手段,局限性及其在非小细胞肺癌诊治中的应用。.
Similar articles
-
[Advances in Clinical Application of Liquid Biopsy in Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2021 Oct 20;24(10):723-728. doi: 10.3779/j.issn.1009-3419.2021.102.33. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34696544 Free PMC article. Chinese.
-
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.Curr Treat Options Oncol. 2021 Aug 23;22(10):86. doi: 10.1007/s11864-021-00882-9. Curr Treat Options Oncol. 2021. PMID: 34424428 Review.
-
Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.Crit Rev Oncol Hematol. 2015 Feb;93(2):90-102. doi: 10.1016/j.critrevonc.2014.10.001. Epub 2014 Oct 12. Crit Rev Oncol Hematol. 2015. PMID: 25459665 Review.
-
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.Curr Oncol Rep. 2018 Jul 20;20(9):70. doi: 10.1007/s11912-018-0720-z. Curr Oncol Rep. 2018. PMID: 30030656 Review.
-
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer.Hematol Oncol Clin North Am. 2023 Jun;37(3):475-487. doi: 10.1016/j.hoc.2023.02.005. Epub 2023 Apr 4. Hematol Oncol Clin North Am. 2023. PMID: 37024388 Review.
Cited by
-
Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer.Oncol Lett. 2018 Oct;16(4):4400-4406. doi: 10.3892/ol.2018.9211. Epub 2018 Jul 25. Oncol Lett. 2018. PMID: 30250539 Free PMC article.
References
-
- Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. http://www.thelancet.com/journals/lancet/article/PIIS0140673603130796/ab... Lancet. 2003;61(9366):1326–1330. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical